US Stock MarketDetailed Quotes

XBIO Xenetic Biosciences

Watchlist
  • 3.6079
  • +0.0579+1.63%
Close May 17 16:00 ET
5.56MMarket Cap-1231P/E (TTM)

Xenetic Biosciences Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Total revenue
-15.69%510.82K
48.80%2.54M
37.99%671.96K
47.54%611.17K
56.22%651.01K
55.75%605.84K
47.06%1.71M
46.41%486.97K
18.60%414.25K
44.89%416.71K
Operating revenue
-15.69%510.82K
48.80%2.54M
37.99%671.96K
47.54%611.17K
56.22%651.01K
55.75%605.84K
47.06%1.71M
46.41%486.97K
18.60%414.25K
44.89%416.71K
Cost of revenue
Gross profit
Operating expense
16.98%1.78M
-16.25%7.06M
-5.98%1.93M
39.29%1.76M
-40.42%1.85M
-24.28%1.52M
21.97%8.42M
-7.08%2.05M
-26.85%1.26M
119.31%3.1M
Selling and administrative expenses
-9.81%834.91K
-2.55%3.56M
11.06%952K
-14.60%737.24K
-7.83%945.95K
2.03%925.74K
-2.40%3.65M
-12.32%857.17K
-8.66%863.23K
15.22%1.03M
-General and administrative expense
-9.81%834.91K
-2.55%3.56M
11.06%952K
-14.60%737.24K
-7.83%945.95K
2.03%925.74K
-2.40%3.65M
-12.32%857.17K
-8.66%863.23K
15.22%1.03M
Research and development costs
58.64%944.32K
-26.75%3.49M
-18.23%975.63K
155.92%1.02M
-56.52%903.24K
-45.95%595.28K
50.81%4.77M
-2.92%1.19M
-48.88%398.8K
296.05%2.08M
Operating profit
-38.60%-1.27M
32.78%-4.52M
19.68%-1.26M
-35.26%-1.15M
55.41%-1.2M
43.50%-915.18K
-16.90%-6.72M
16.58%-1.56M
38.39%-847.79K
-138.29%-2.69M
Net non-operating interest income expense
35.39%73.25K
112.83%355.76K
4.95%83.76K
101.86%91.8K
689.87%126.1K
108.84%54.1K
66.38%167.15K
171.07%79.81K
62.24%45.48K
-23.00%15.97K
Non-operating interest income
35.39%73.25K
112.83%355.76K
4.95%83.76K
101.86%91.8K
689.87%126.1K
108.84%54.1K
66.38%167.15K
171.07%79.81K
62.24%45.48K
-23.00%15.97K
Other net income (expense)
-98.85%52
1,689.23%25.38K
-59.03%404
60.96%-666
2,063.01%21.12K
2,171.36%4.52K
-242.72%-1.6K
-66.04%986
41.29%-1.71K
-552.10%-1.08K
Other non- operating income (expenses)
-98.85%52
1,689.23%25.38K
-59.03%404
60.96%-666
2,063.01%21.12K
2,171.36%4.52K
-242.72%-1.6K
-66.04%986
41.29%-1.71K
-552.10%-1.08K
Income before tax
-39.53%-1.2M
36.90%-4.13M
20.98%-1.17M
-31.29%-1.06M
60.67%-1.05M
46.25%-856.55K
-16.07%-6.55M
19.50%-1.48M
40.48%-804.02K
-141.46%-2.67M
Income tax
Net income
-39.53%-1.2M
36.90%-4.13M
20.98%-1.17M
-31.29%-1.06M
60.67%-1.05M
46.25%-856.55K
-16.07%-6.55M
19.50%-1.48M
40.48%-804.02K
-141.46%-2.67M
Net income continuous Operations
-39.53%-1.2M
36.90%-4.13M
20.98%-1.17M
-31.29%-1.06M
60.67%-1.05M
46.25%-856.55K
-16.07%-6.55M
19.50%-1.48M
40.48%-804.02K
-141.46%-2.67M
Minority interest income
Net income attributable to the parent company
-39.53%-1.2M
36.90%-4.13M
20.98%-1.17M
-31.29%-1.06M
60.67%-1.05M
46.25%-856.55K
-16.07%-6.55M
19.50%-1.48M
40.48%-804.02K
-141.46%-2.67M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-39.53%-1.2M
36.90%-4.13M
20.98%-1.17M
-31.29%-1.06M
60.67%-1.05M
46.25%-856.55K
-16.07%-6.55M
19.50%-1.48M
40.48%-804.02K
-141.46%-2.67M
Basic earnings per share
-39.29%-0.78
41.21%-2.71
20.62%-0.77
-23.21%-0.69
63.68%-0.69
53.33%-0.56
16.18%-4.61
30.71%-0.97
56.92%-0.56
-46.15%-1.9
Diluted earnings per share
-39.29%-0.78
41.21%-2.71
20.62%-0.77
-23.21%-0.69
63.68%-0.69
53.33%-0.56
16.18%-4.61
30.71%-0.97
56.92%-0.56
-46.15%-1.9
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Total revenue -15.69%510.82K48.80%2.54M37.99%671.96K47.54%611.17K56.22%651.01K55.75%605.84K47.06%1.71M46.41%486.97K18.60%414.25K44.89%416.71K
Operating revenue -15.69%510.82K48.80%2.54M37.99%671.96K47.54%611.17K56.22%651.01K55.75%605.84K47.06%1.71M46.41%486.97K18.60%414.25K44.89%416.71K
Cost of revenue
Gross profit
Operating expense 16.98%1.78M-16.25%7.06M-5.98%1.93M39.29%1.76M-40.42%1.85M-24.28%1.52M21.97%8.42M-7.08%2.05M-26.85%1.26M119.31%3.1M
Selling and administrative expenses -9.81%834.91K-2.55%3.56M11.06%952K-14.60%737.24K-7.83%945.95K2.03%925.74K-2.40%3.65M-12.32%857.17K-8.66%863.23K15.22%1.03M
-General and administrative expense -9.81%834.91K-2.55%3.56M11.06%952K-14.60%737.24K-7.83%945.95K2.03%925.74K-2.40%3.65M-12.32%857.17K-8.66%863.23K15.22%1.03M
Research and development costs 58.64%944.32K-26.75%3.49M-18.23%975.63K155.92%1.02M-56.52%903.24K-45.95%595.28K50.81%4.77M-2.92%1.19M-48.88%398.8K296.05%2.08M
Operating profit -38.60%-1.27M32.78%-4.52M19.68%-1.26M-35.26%-1.15M55.41%-1.2M43.50%-915.18K-16.90%-6.72M16.58%-1.56M38.39%-847.79K-138.29%-2.69M
Net non-operating interest income expense 35.39%73.25K112.83%355.76K4.95%83.76K101.86%91.8K689.87%126.1K108.84%54.1K66.38%167.15K171.07%79.81K62.24%45.48K-23.00%15.97K
Non-operating interest income 35.39%73.25K112.83%355.76K4.95%83.76K101.86%91.8K689.87%126.1K108.84%54.1K66.38%167.15K171.07%79.81K62.24%45.48K-23.00%15.97K
Other net income (expense) -98.85%521,689.23%25.38K-59.03%40460.96%-6662,063.01%21.12K2,171.36%4.52K-242.72%-1.6K-66.04%98641.29%-1.71K-552.10%-1.08K
Other non- operating income (expenses) -98.85%521,689.23%25.38K-59.03%40460.96%-6662,063.01%21.12K2,171.36%4.52K-242.72%-1.6K-66.04%98641.29%-1.71K-552.10%-1.08K
Income before tax -39.53%-1.2M36.90%-4.13M20.98%-1.17M-31.29%-1.06M60.67%-1.05M46.25%-856.55K-16.07%-6.55M19.50%-1.48M40.48%-804.02K-141.46%-2.67M
Income tax
Net income -39.53%-1.2M36.90%-4.13M20.98%-1.17M-31.29%-1.06M60.67%-1.05M46.25%-856.55K-16.07%-6.55M19.50%-1.48M40.48%-804.02K-141.46%-2.67M
Net income continuous Operations -39.53%-1.2M36.90%-4.13M20.98%-1.17M-31.29%-1.06M60.67%-1.05M46.25%-856.55K-16.07%-6.55M19.50%-1.48M40.48%-804.02K-141.46%-2.67M
Minority interest income
Net income attributable to the parent company -39.53%-1.2M36.90%-4.13M20.98%-1.17M-31.29%-1.06M60.67%-1.05M46.25%-856.55K-16.07%-6.55M19.50%-1.48M40.48%-804.02K-141.46%-2.67M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -39.53%-1.2M36.90%-4.13M20.98%-1.17M-31.29%-1.06M60.67%-1.05M46.25%-856.55K-16.07%-6.55M19.50%-1.48M40.48%-804.02K-141.46%-2.67M
Basic earnings per share -39.29%-0.7841.21%-2.7120.62%-0.77-23.21%-0.6963.68%-0.6953.33%-0.5616.18%-4.6130.71%-0.9756.92%-0.56-46.15%-1.9
Diluted earnings per share -39.29%-0.7841.21%-2.7120.62%-0.77-23.21%-0.6963.68%-0.6953.33%-0.5616.18%-4.6130.71%-0.9756.92%-0.56-46.15%-1.9
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg